Biotech

All Articles

Orion to make use of Aitia's 'digital doubles' to find new cancer medicines

.Finnish biotech Orion has spied prospective in Aitia's "electronic twin" specialist to create brand...

Windtree's shock med brings up high blood pressure in newest stage 2 gain

.While Windtree Therapeutics has battled to grow the monetary origins needed to have to make it thro...

2 cancer biotechs combine, creating worldwide impact

.OncoC4 is actually taking AcroImmune-- and also its in-house clinical manufacturing functionalities...

Amgen records 1st stage 3 win for $400M chronic eczema medication

.Amgen has actually discussed (PDF) the very first stage 3 records on its $400 thousand chronic ecze...

Biogen, UCB document phase 3 lupus gain after falling short earlier trial

.Biogen as well as UCB's bank on improving right into stage 3 on the back of an unsuccessful researc...

Aptadir hopes brand new RNA preventions can reverse tricky cancers

.Italian biotech Aptadir Therapeutics has released with the guarantee that its pipeline of preclinic...

Wave surfs DMD excellence to regulatory authorities' doors, sending stock up

.Wave Life Sciences has fulfilled its goal in a Duchenne muscular dystrophy (DMD) study, placing it ...

Sanofi picks brand-new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma fold, takin...

Achilles splashes cell therapy program, supports for cutbacks after missing 'industrial feasibility' objectives

.Achilles Therapies has wrecked its own tactic. The English biotech is actually quiting working on i...

Aligos declares stage 2 MASH succeed, slashing liver body fat up to 46%

.Aligos Therapies is proclaiming a midstage win in metabolic-dysfunction associated steatohepatitis ...